Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Glycemic Control in Adults With Type 1 Diabetes When Switching to Insulin Degludec

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: RETROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* People with T1D ≥18 years at the moment of switch to Insulin Degludec~* Diagnosed with T1D ≥2 years before switch to Insulin Degludec~* On basal-bolus insulin therapy with insulin pens ≥2 years before switch to Insulin Degludec~* ≥6 months use of Insulin Degludec at moment of datacollection~* Using continuous glucose monitoring ≥2 years before switch to Insulin Degludec~Exclusion Criteria:~* People with T1D \<18 years at the moment of switch to Insulin Degludec~* People without T1D or with T1D \<2 years before switch to Insulin Degludec~* Women with T1D who are pregnant or planning pregnancy during -12 and +12 months~* Not using basal-bolus insulin therapy with insulin pens during -24 and +6 months~* Start to use non-insulin antidiabetic agents between -12 and +12 months~* Having received treatment with oral or injectable corticosteroids during -12 and +12 months~* Undergoing hemodialysis, renal transplantation, or beta cell transplantation during -12 and +12 months~* \<6 months use of Insulin Degludec at moment of datacollection~* Not using continuous glucose monitoring or \<2 years before switch to Insulin Degludec

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Study cohort (Type: None): People with type 1 diabetes who switched to Insulin Degludec from another basal insulin between 1/5/2019 and 1/6/2021 in the two participating sensors

Based on this trial design, predict the completion outcome and termination type (if applicable).